Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Banker

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Drug Metabolism|November 11, 2008
Plasma/serum protein binding determinationsMichael J Banker, Tracey H Clark
Journal of Pharmaceutical Sciences|April 25, 2003
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingMichael J Banker, Tracey H Clark, John A Williams
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|February 4, 2010
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organismsKristen C Nelson, David A Andow, Michael J Banker
Toxicology Letters|June 26, 2010
Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studiesJohn W Benbow, Jiri Aubrecht, Michael J Banker, et al.
Journal of Medicinal Chemistry|September 21, 2011
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)Travis T Wager, Betty A Pettersen, Anne W Schmidt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Drug Metabolism|November 11, 2008
Plasma/serum protein binding determinationsMichael J Banker, Tracey H Clark
Journal of Pharmaceutical Sciences|April 25, 2003
Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein bindingMichael J Banker, Tracey H Clark, John A Williams
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|February 4, 2010
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organismsKristen C Nelson, David A Andow, Michael J Banker
Toxicology Letters|June 26, 2010
Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studiesJohn W Benbow, Jiri Aubrecht, Michael J Banker, et al.
Journal of Medicinal Chemistry|September 21, 2011
Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)Travis T Wager, Betty A Pettersen, Anne W Schmidt, et al.
Pageof 1